Sign in
4

Changes in Ownership

GYRE THERAPEUTICS, INC. Filed Acc 0001209191-20-016061

Director bought 2,000 shares at $5.78 ($11,560)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Williams Eddie Director 2020-03-04 Purchase +2,000 $5.78 $11,560 10,839 D: show line 1 in the form
Open-market purchases · 2,000 sh · avg $5.78 · $11,560
Loading xslF345X03/doc4.xml…